CTI, Mobile PET launch European PET unit
CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals.
CTI PET Systems (CPS), the joint venture between CTI and Siemens Nuclear Medicine Group, has expanded its partnership with Mobile PET Systems. The two companies announced last month the launch of a mobile PET operation that will serve European hospitals. Knoxville, TN-based CPS will provide an ECAT PET scanner.
Sparked by Mobile PET Systems successful debut of mobile PET services at the October European Association of Nuclear Medicine meeting in Barcelona, Spain, the deal makes San Diego, CA-based Mobile PET the first company to provide mobile ECAT PET imaging technology in Europe, the two firms said. Mobile PET expects to begin service within the next three months through Mobile PET Systems Europe, a joint venture it formed with Neuromed of Germany.
The deal adds to the momentum Mobile PET has been enjoying since December 1998 when the company went public, bolstered by a favorable reimbursement market for PET. In February, the firm bought five mobile coaches from Calumet Coach of Calumet City, IL, expanding its service capability, and in March, received a $10 million line of credit from Finova Capital, which it has used to cover the purchase of five Siemens ECAT Exact PET cameras (SCAN 2/17/99 and 3/31/99).
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
